(+)-catechin multiple interactions ISO RGD:736644 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of FGFR4 mRNA CTD PMID:24763279 1,2-dimethylhydrazine increases expression ISO RGD:736645 6480464 1, 2-Dimethylhydrazine results in increased expression of FGFR4 mRNA CTD PMID:22206623 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736645 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGFR4 mRNA CTD PMID:19770486 , PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 , PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736645 6480464 Tetrachlorodibenzodioxin affects the expression of FGFR4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGFR4 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FGFR4 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FGFR4 mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736645 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR4 mRNA CTD PMID:31009676 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of FGFR4 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:736645 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FGFR4 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:736645 6480464 Fenretinide results in increased expression of FGFR4 mRNA CTD PMID:28973697 acrylamide increases expression ISO RGD:736644 6480464 Acrylamide results in increased expression of FGFR4 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:736644 6480464 Aflatoxin B1 affects the expression of FGFR4 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:736644 6480464 Aflatoxin B1 results in decreased methylation of FGFR4 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:736645 6480464 Aflatoxin B1 results in decreased expression of FGFR4 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:736644 6480464 Tretinoin results in decreased expression of FGFR4 mRNA CTD PMID:7680553 arsane decreases expression ISO RGD:736645 6480464 Arsenic results in decreased expression of FGFR4 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:736645 6480464 Arsenic results in decreased expression of FGFR4 mRNA CTD PMID:19654921 benomyl increases expression EXP 6480464 Benomyl results in increased expression of FGFR4 mRNA CTD PMID:15885261 benzo[a]pyrene decreases expression ISO RGD:736645 6480464 Benzo(a)pyrene results in decreased expression of FGFR4 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:736644 6480464 Benzo(a)pyrene affects the methylation of FGFR4 5' UTR, Benzo(a)pyrene affects the methylation of FGFR4 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:736644 6480464 Benzo(a)pyrene results in decreased expression of FGFR4 mRNA CTD PMID:20106945 more ... bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FGFR4 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:736645 6480464 bisphenol A results in increased expression of FGFR4 mRNA CTD PMID:34585602 bisphenol A affects expression ISO RGD:736644 6480464 bisphenol A affects the expression of FGFR4 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FGFR4 gene CTD PMID:28505145 buta-1,3-diene decreases expression ISO RGD:736645 6480464 1, 3-butadiene results in decreased expression of FGFR4 mRNA CTD PMID:29038090 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of FGFR4 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:736644 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FGFR4 mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FGFR4 mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:736644 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FGFR4 mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO RGD:736644 6480464 Caffeine results in decreased phosphorylation of FGFR4 protein CTD PMID:35688186 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of FGFR4 gene CTD PMID:30521419 carbon nanotube decreases expression ISO RGD:736645 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression ISO RGD:736645 6480464 Chloroprene results in decreased expression of FGFR4 mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of FGFR4 mRNA CTD PMID:17589599 cholesterol affects metabolic processing ISO RGD:736645 6480464 FGFR4 protein affects the metabolism of Cholesterol CTD PMID:11956156 cholesterol decreases metabolic processing ISO RGD:736644 6480464 FGFR4 protein results in decreased metabolism of Cholesterol CTD PMID:15750181 chromium(6+) affects expression ISO RGD:736645 6480464 chromium hexavalent ion affects the expression of FGFR4 mRNA CTD PMID:28472532 cisplatin decreases expression ISO RGD:736644 6480464 Cisplatin results in decreased expression of FGFR4 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:736645 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:736645 6480464 Clofibrate results in decreased expression of FGFR4 mRNA CTD PMID:23811191 clofibric acid decreases expression EXP 6480464 Clofibric Acid results in decreased expression of FGFR4 mRNA CTD PMID:15833021 clofibric acid multiple interactions EXP 6480464 [Clofibric Acid co-treated with Diethylnitrosamine] results in decreased expression of FGFR4 mRNA CTD PMID:15833021 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FGFR4 mRNA CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of FGFR4 mRNA CTD PMID:22465980 copper atom multiple interactions ISO RGD:736644 6480464 [Chelating Agents binds to Copper] which results in decreased expression of FGFR4 mRNA CTD PMID:30911355 , PMID:31162603 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of FGFR4 mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RGD:736644 6480464 [Chelating Agents binds to Copper] which results in decreased expression of FGFR4 mRNA CTD PMID:30911355 , PMID:31162603 copper(II) sulfate decreases expression ISO RGD:736644 6480464 Copper Sulfate results in decreased expression of FGFR4 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:736644 6480464 coumarin results in increased phosphorylation of FGFR4 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:736645 6480464 Asbestos, Crocidolite results in increased expression of FGFR4 mRNA CTD PMID:29279043 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of FGFR4 protein CTD PMID:15770714 cyclosporin A decreases expression ISO RGD:736644 6480464 Cyclosporine results in decreased expression of FGFR4 mRNA CTD PMID:20106945 more ... cyclosporin A decreases expression ISO RGD:736645 6480464 Cyclosporine results in decreased expression of FGFR4 mRNA CTD PMID:19770486 cyclosporin A multiple interactions EXP 6480464 [Thioacetamide co-treated with Cyclosporine] results in decreased expression of FGFR4 protein CTD PMID:15770714 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of FGFR4 mRNA CTD PMID:15885261 dexamethasone multiple interactions ISO RGD:736645 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR4 mRNA CTD PMID:31009676 dextran sulfate increases expression ISO RGD:736645 6480464 Dextran Sulfate results in increased expression of FGFR4 mRNA CTD PMID:27580383 diazinon increases expression EXP 6480464 Diazinon results in increased expression of FGFR4 mRNA CTD PMID:17589599 , PMID:19130878 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FGFR4 mRNA CTD PMID:21266533 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of FGFR4 mRNA CTD PMID:19130878 dioxygen multiple interactions ISO RGD:736645 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGFR4 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:736644 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR4 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FGFR4 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:736645 6480464 epoxiconazole results in increased expression of FGFR4 mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of FGFR4 mRNA CTD PMID:29769550 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of FGFR4 mRNA CTD PMID:28263823 flutamide increases expression EXP 6480464 Flutamide results in increased expression of FGFR4 mRNA CTD PMID:15885261 furosemide affects expression EXP 6480464 Furosemide affects the expression of FGFR4 mRNA CTD PMID:16526316 gossypol multiple interactions ISO RGD:736645 6480464 [gossypol acetic acid results in increased abundance of Gossypol] promotes the reaction [ponatinib results in decreased expression of FGFR4 mRNA] more ... CTD PMID:34699866 GW 4064 multiple interactions ISO RGD:736645 6480464 FGFR4 protein affects the reaction [[GW 4064 results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA] CTD PMID:22467244 heparan sulfate affects binding ISO RGD:736644 6480464 Heparitin Sulfate analog binds to FGFR4 protein CTD PMID:11278860 heparin affects binding ISO RGD:736644 6480464 Heparin analog binds to FGFR4 protein CTD PMID:11278860 heparin multiple interactions EXP 6480464 Heparin affects the reaction [FGF1 protein binds to FGFR4 protein], Heparin affects the reaction [FGF2 protein binds to FGFR4 protein] CTD PMID:10336501 heparin multiple interactions ISO RGD:736644 6480464 Heparin promotes the reaction [FGF19 protein binds to FGFR4 protein], Heparin promotes the reaction [FGFR4 protein binds to FGFR4 protein] CTD PMID:10525310 , PMID:10736564 hydrogen peroxide increases expression ISO RGD:736644 6480464 Hydrogen Peroxide results in increased expression of FGFR4 mRNA CTD PMID:31162603 lead diacetate decreases expression ISO RGD:736645 6480464 lead acetate results in decreased expression of FGFR4 mRNA CTD PMID:22609695 mono(2-ethylhexyl) phthalate increases expression ISO RGD:736645 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of FGFR4 mRNA CTD PMID:31009676 N-methyl-N-nitrosourea multiple interactions EXP 6480464 Methylnitrosourea results in increased expression of and affects the localization of FGFR4 protein CTD PMID:15581186 N-nitrosodiethylamine decreases response to substance ISO RGD:736645 6480464 FGFR4 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:19009564 N-nitrosodiethylamine multiple interactions EXP 6480464 [Clofibric Acid co-treated with Diethylnitrosamine] results in decreased expression of FGFR4 mRNA CTD PMID:15833021 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of FGFR4 mRNA CTD PMID:17032414 nickel atom affects expression EXP 6480464 Nickel affects the expression of FGFR4 mRNA CTD PMID:19130878 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FGFR4 mRNA CTD PMID:26720608 obeticholic acid decreases expression ISO RGD:736644 6480464 obeticholic acid results in decreased expression of FGFR4 mRNA CTD PMID:27939613 okadaic acid decreases phosphorylation ISO RGD:736645 6480464 Okadaic Acid results in decreased phosphorylation of FGFR4 protein CTD PMID:8576110 ozone multiple interactions ISO RGD:736645 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FGFR4 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FGFR4 mRNA CTD PMID:34911549 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of FGFR4 mRNA CTD PMID:27638505 paracetamol multiple interactions ISO RGD:736645 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:736645 6480464 Acetaminophen affects the expression of FGFR4 mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of FGFR4 mRNA CTD PMID:32680482 PD173074 multiple interactions ISO RGD:736644 6480464 PD 173074 inhibits the reaction [FGF1 protein results in increased phosphorylation of FGFR4 protein] CTD PMID:15709206 PD173074 decreases activity ISO RGD:736644 6480464 PD 173074 results in decreased activity of FGFR4 protein CTD PMID:15377668 perfluorooctane-1-sulfonic acid affects expression ISO RGD:736645 6480464 perfluorooctane sulfonic acid affects the expression of FGFR4 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:736645 6480464 perfluorooctanoic acid affects the expression of FGFR4 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:736644 6480464 perfluorooctanoic acid results in decreased expression of FGFR4 protein CTD PMID:26879310 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of FGFR4 mRNA CTD PMID:19162173 phenylmercury acetate decreases expression ISO RGD:736644 6480464 Phenylmercuric Acetate results in decreased expression of FGFR4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736644 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR4 mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:736645 6480464 Phosgene affects the expression of FGFR4 mRNA CTD PMID:16300373 pirinixic acid multiple interactions ISO RGD:736644 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FGFR4 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:736645 6480464 pirinixic acid results in decreased expression of FGFR4 mRNA CTD PMID:20813756 , PMID:23811191 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FGFR4 mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO RGD:736645 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of FGFR4 mRNA CTD PMID:20813756 ponatinib decreases activity ISO RGD:736644 6480464 ponatinib analog results in decreased activity of FGFR4 protein, ponatinib results in decreased activity of FGFR4 protein CTD PMID:19878872 , PMID:21561767 ponatinib decreases expression ISO RGD:736645 6480464 ponatinib results in decreased expression of FGFR4 mRNA CTD PMID:34699866 ponatinib multiple interactions ISO RGD:736645 6480464 [gossypol acetic acid results in increased abundance of Gossypol] promotes the reaction [ponatinib results in decreased expression of FGFR4 mRNA], ponatinib promotes the reaction [[gossypol acetic acid results in increased abundance of Gossypol] which results in decreased expression of FGFR4 mRNA] CTD PMID:34699866 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:736645 6480464 Pregnenolone Carbonitrile results in decreased expression of FGFR4 mRNA CTD PMID:28903501 quercetin decreases expression ISO RGD:736644 6480464 Quercetin results in decreased expression of FGFR4 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:736644 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR4 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:736644 6480464 Silicon Dioxide analog results in decreased expression of FGFR4 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:736644 6480464 sodium arsenite results in increased expression of FGFR4 mRNA CTD PMID:12377979 sulindac sulfide decreases expression ISO RGD:736644 6480464 sulindac sulfide results in decreased expression of FGFR4 mRNA CTD PMID:16184548 taurocholic acid multiple interactions ISO RGD:736645 6480464 FGFR4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA], FGFR4 protein affects the reaction [Taurocholic Acid results in decreased expression of PON1 mRNA] CTD PMID:16284190 testosterone decreases expression ISO RGD:736644 6480464 Testosterone results in decreased expression of FGFR4 mRNA CTD PMID:33359661 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FGFR4 mRNA CTD PMID:16644059 , PMID:17805973 tetrachloromethane decreases response to substance ISO RGD:736645 6480464 FGFR4 protein results in decreased susceptibility to Carbon Tetrachloride CTD PMID:12466116 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FGFR4 mRNA CTD PMID:17032414 thioacetamide multiple interactions EXP 6480464 [Thioacetamide co-treated with Cyclosporine] results in decreased expression of FGFR4 protein CTD PMID:15770714 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FGFR4 protein CTD PMID:15770714 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FGFR4 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:736645 6480464 titanium dioxide results in decreased expression of FGFR4 mRNA CTD PMID:27760801 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FGFR4 mRNA CTD PMID:33387578 triptonide increases expression ISO RGD:736645 6480464 triptonide results in increased expression of FGFR4 mRNA CTD PMID:33045310 valproic acid increases expression ISO RGD:736644 6480464 Valproic Acid results in increased expression of FGFR4 mRNA CTD PMID:28001369 zoledronic acid decreases expression ISO RGD:736644 6480464 zoledronic acid results in decreased expression of FGFR4 mRNA CTD PMID:24714768